Key Takeaways
- 25% revenue growth, demand-led: Agrochemical volumes rose 11% and non-agrochemical 59%, with management calling it "demand on the ground" rather than restocking.
- Gross margin surged to 35.5%: A 630 bps YoY jump driven by input cost stabilization and the end of the channel destocking turmoil that depressed the prior 1.5 years.
- Europe delivered the quarter: Revenue grew 43% YoY on good agrochemical demand and favorable weather, while a 12% Euro appreciation against the USD provided a straight forex benefit worth ~13% of revenue growth.
- Management declined to explain the cost structure: When asked why EBITDA margin improved only 360 bps against a 630 bps gross margin jump, and why non-agrochemical realizations are deeply negative, management said it could not comment and directed analysts to write in offline.
- What to watch next quarter: Whether the 25% revenue growth pace holds, whether gross margins sustain at 35%–36% as promised, and whether management begins to address the unexplained gap between gross and EBITDA margin expansion.
Demand & Volume Recovery
- Broad-based volume growth: Agrochemical volumes grew 11% YoY while non-agrochemical volumes jumped 59% YoY, reflecting a global revival in demand and inventories returning to normal across distribution channels.
- Demand, not restocking: Management stated the volume growth reflects genuine end-market demand rather than channel refilling, a key distinction for assessing sustainability.
- Europe led the recovery: European revenues grew 43% YoY, supported by good agrochemical demand and favorable weather conditions that aided the agricultural business.
- Non-agrochemical is lumpy by nature: The business is tailor-made, with customers buying per specific requirement that typically does not repeat, making quarter-to-quarter comparisons inherently volatile.
- Non-agrochemical realization declined sharply: Volume grew 59% but revenue grew only 31%, a negative realization trend spanning three quarters that management said it had not analyzed and could not comment on.
Bubna: "I feel it is demand on the ground."
Margins: The Expansion & The Unexplained Gap
- Gross margin surged to 35.5%: The 630 bps YoY expansion was driven by input cost stabilization and normalization from an abnormal prior period when channel inventories were high and prices severely depressed, with no substantial inventory gains in the quarter.
- Europe carried the margin story: European region gross margins reached 43%, and with Europe commanding a high share of total revenues, it pulled the blended company margin to 35%. NAFTA stood at 26%, LATAM at 28%, and rest of world at 26.5%.
- Management expects margins to sustain: Gross margins are forecast to remain in the 35%–36% range for the full year, with confidence rooted in much better business stability now that the turmoil of the prior 1.5 years has ended.
- EBITDA margin improved far less than gross margin: EBITDA margin rose only 360 bps YoY versus the 630 bps gross margin expansion, implying a sharp jump in other expenses despite strong volume growth. Management declined to answer the question on the call, directing analysts to write in offline.
- Freight costs are rising: Freight rates have increased substantially due to worldwide conflicts, particularly Iran, Israel and Red Sea disturbances, and the trend is getting higher, also increasing travel time.
Bubna: "We feel it is sustainable."
Pricing & Foreign Exchange
- Forex provided a material tailwind: Approximately 45% of sales are in Euro or local European currencies while sourcing is in USD. The Euro moved from ~$1.03–$1.04 to ~$1.17, a 12%+ increase, contributing roughly 13% to reported revenue growth.
- Pricing is improving slowly: Prices have improved over the previous quarter, with management describing the rate of increase as very slow but steady. Price and product mix was negative 1% in the quarter.
- Registration age drives margin compression: Newer registrations deliver better margins, while older registrations face more competition and margins get distributed downward over time, creating a natural lifecycle drag that must be offset by fresh registrations.
- Management declined to quantify European price increases: When asked for a specific percentage, management said it did not have the figure and was making only a general statement.
Non-Agrochemical Business: Unanswered Questions
- Volume exploded but realization collapsed: Non-agrochemical volume grew 59% YoY while value grew only 31%, implying a negative realization of roughly 28% that has persisted for three quarters. Management attributed it to lower-value products selling more in the quarter.
- Operating margin stability contradicts realization decline: An analyst noted that non-agrochemical operating margins have remained stable around 21%–23% despite the sharp realization drop, an apparent contradiction. Management declined to answer, saying it would need to look into it.
- Management had not analyzed the trend: When first asked about the negative realization, management stated it had not looked at the issue from that angle and could not comment instantly, suggesting limited internal scrutiny of a material business segment.
Capital Allocation & Tariffs
- Cash is building, deployment philosophy is conservative: With cash approaching ~₹800 cr even after a planned ₹400–₹450 cr CAPEX program, management said it wants to run the business comfortably and be ready for adverse situations. It declared two dividends in the quarter and said it will be more liberal with payouts, but gave no specific commitment or target.
- Tariff impact seen as minimal: Management believes China is the factory to the world with few alternative sources, and the company can pass on tariff increases to US customers who accept it gracefully knowing the situation.
- No pre-buy distortion in non-agrochemicals: When US tariffs spiked to 125% then dropped to ~30%, customers rushed to buy fearing a return to 100%, but management confirmed no pre-buy element affected the non-agrochemical business.
Bubna: "We want to run our business very comfortably and peacefully. So we are ready for any adverse situations and still be able to maintain our business."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 15% growth for FY26 | FY26 |
| Gross margin | Sustain at 35%–36% | FY26 full year |
| EBITDA margin | 15%–18% range, trending toward the higher side of 15% or above 18% | FY26 |
| CAPEX | ₹400–₹450 cr backed by strong pipeline | FY26 |
| Revenue growth pace | 25% sales growth can sustain over coming quarters | Coming quarters |
| Forex levels | Remain at same level | FY26 |
| Product registrations | Aim to increase | Ongoing |
| Dividend posture | More liberal in payouts, dividends, rewarding shareholders | No timeline given |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Revenue | ₹985 cr, +25% YoY |
| Agrochemical revenue | ₹846 cr, +25% YoY |
| Non-agrochemical revenue | ₹139 cr, +31% YoY |
| Overall volume growth | 13.2% YoY |
| Gross margin | 35.5%, +630 bps YoY from 29.2% |
| EBITDA | ₹142 cr, +67% YoY |
| EBITDA margin | 14.4% |
| PAT | ₹143 cr, +424% YoY from ₹27 cr |
| Revenue growth composition | Volume ~13%, forex ~13%, price and product mix negative 1% |
| Gross margin, Europe | 43% |
| Gross margin, NAFTA | 26% |
| Gross margin, LATAM | 28% |
| Gross margin, rest of world | 26.5% |
| Working capital days | 100 days, improved 18 days vs March 2025 |
| CAPEX | ₹114 cr for the quarter |
| Cash, bank and liquid investments | ₹791 cr as on 30 June 2025 |
| Total product registrations | 2,981 as on 30 June 2025, with 1,021 applications at approval stage |
| FY26 revenue growth guidance | 15% |
| FY26 EBITDA margin guidance | 15%–18% |
| FY26 planned CAPEX | ₹400–₹450 cr |
| Top 10 molecules revenue share | 36% of total revenue, vs 38% in Q1 last year |